Clinical Trial VICCHEM1137


MicroRNAs in Myelodysplastic Syndrome

Principal Investigator(s)

Annette Kim


  • Protocol No. VICCHEM1137
  • Open Date: 07/22/2011
  • Staging: NA
  • Age Group: Adults
  • Scope: National
  • Objective: Determine the contribution of hypermethylation in the dysregulation of miRNA expression in MDS.
  • Disease Sites:
  • Therapies: Correlative
  • Drugs: None Specified
  • Participating Institutions: Boston Baskin Cancer Group (UTCI); Vanderbilt University; Jackson-Madison County Hospital; Roswell Park Cancer Institute; The Jones Clinic; Thomas Jefferson University Hospital
  • Secondary Protocol No: Not Specified



Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.